Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-27

Clinical Trial Update: Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services [NA]

View source ↗

Summary

A completed clinical trial evaluating pharmacist discharge medication services to reduce 30-day readmissions in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure, Patient Readmission | NA | Status: COMPLETED